Greenbrook TMS Inc
TSX:GTMS

Watchlist Manager
Greenbrook TMS Inc Logo
Greenbrook TMS Inc
TSX:GTMS
Watchlist
Price: 0.97 CAD -15.65% Market Closed
Market Cap: CA$28.6m

Operating Margin

-32.2%
Current
Improving
by 0.6%
vs 3-y average of -32.8%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-32.2%
=
Operating Income
$-30.7m
/
Revenue
$69.1m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-32.2%
=
Operating Income
CA$-30.7m
/
Revenue
$69.1m

Peer Comparison

Country Company Market Cap Operating
Margin
CA
Greenbrook TMS Inc
TSX:GTMS
28.6m CAD
Loading...
US
CVS Health Corp
NYSE:CVS
94.7B USD
Loading...
US
Cigna Corp
NYSE:CI
72.5B USD
Loading...
US
Cigna Group
XMUN:CGN
60.8B EUR
Loading...
DE
Fresenius SE & Co KGaA
XETRA:FRE
27.1B EUR
Loading...
DE
Fresenius Medical Care AG
XMUN:FME
22.2B EUR
Loading...
US
Laboratory Corporation of America Holdings
NYSE:LH
22.5B USD
Loading...
US
Quest Diagnostics Inc
NYSE:DGX
20.5B USD
Loading...
US
Guardant Health Inc
NASDAQ:GH
14B USD
Loading...
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11.1B EUR
Loading...
US
DaVita Inc
NYSE:DVA
7.7B USD
Loading...

Market Distribution

In line with most companies in Canada
Percentile
35th
Based on 4 855 companies
35th percentile
-32.2%
Low
-4 710 029.9% — -65.8%
Typical Range
-65.8% — 11%
High
11% — 71 100%
Distribution Statistics
Canada
Min -4 710 029.9%
30th Percentile -65.8%
Median -2.4%
70th Percentile 11%
Max 71 100%

Greenbrook TMS Inc
Glance View

Market Cap
28.6m CAD
Industry
Health Care

Greenbrook Tms, Inc. engages in the provision of transcranial magnetic stimulation, an FDA-cleared, non-invasive therapy for the treatment of major depressive disorder. The company is headquartered in Toronto, Ontario and currently employs 430 full-time employees. The company went IPO on 2018-10-03. The TMS therapy is a non-invasive therapy for the treatment of depressive disorder (MDD) and other mental health disorders. The TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. The firm's patient-focused, customer service model provides TMS therapy accessible to all patients through three business processes: Patient Inquiry; Patient Conversion; and Treatment Delivery. A course of TMS consists of 36 treatments and a course of treatment consist of an initial cortical mapping and motor threshold determination and treatment, daily treatment sessions and a subsequent motor threshold re-determination and treatment. The company operates through approximately 130 Company-operated treatment centers. The company operates across the States of North Carolina, South Carolina, Maryland, Delaware, Missouri, Illinois, and Ohio.

GTMS Intrinsic Value
Not Available
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-32.2%
=
Operating Income
$-30.7m
/
Revenue
$69.1m
What is Greenbrook TMS Inc's current Operating Margin?

The current Operating Margin for Greenbrook TMS Inc is -32.2%, which is above its 3-year median of -32.8%.

How has Operating Margin changed over time?

Over the last 2 years, Greenbrook TMS Inc’s Operating Margin has decreased from -31.5% to -32.2%. During this period, it reached a low of -35.2% on Dec 31, 2021 and a high of -31.5% on Dec 1, 2020.

Back to Top